ARVC patients (N = 70) were classified as anti-DSG2-ab-positive (N = 38, 54%) and negative (N = 32, 46%) according to the 2 SD U/dL cut-off (Supplementary Table S4). This evidence concerns the gene DSG2 and arrhythmogenic right ventricular cardiomyopathy.